Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Pfizer's new MMP inhibitors selective for MMP-13 and/or TACE

Nov. 17, 1999

Vioxx now available in Canada for treatment of osteoarthritis

Nov. 17, 1999

Cel-Sci, Johns Hopkins collaboration centers on novel strategy for treating autoimmune disease

Nov. 16, 1999

Two Amgen antiarthritics are better than one: synergistic effects of cytokine inhibitors

Nov. 16, 1999

Anakinra plus methotrexate effective, safe in patients not responding to MTX alone

Nov. 16, 1999

News from ACR/ARHP: Amgen's TNF-targeting therapy is effective in RA

Nov. 16, 1999

Centaur presents new antiarthritic drug candidate, the free radical spin trap NRT-115

Nov. 16, 1999

Hydroxamate-based metalloproteinase inhibitors in the P&G pipeline

Nov. 16, 1999

Isis presents findings for antisense treatment of RA at ACR

Nov. 16, 1999

COX-2 inhibitor MK-663 provides significant pain relief in osteoarthritic patients

Nov. 16, 1999

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...